Excellence in Dermatology™
Excellence in Dermatologic Surgery™
Excellence in Medical Dermatology™
Excellence in Dermatopathology™

Return to program book search

Session Information

FOC U072 - Evidence-Based Management of the Iatrogenically Immunocompromised Patient

Open admission to eligible categories, no tuition or ticket


Date: Tuesday, March 05

CME Credits: 1.50

Location: Room C225/226

Time: 7:15 AM - 8:45 AM

Director: Peggy Wu, MD, FAAD

Learning Objectives:
Following this course, the attendee should be able to:

  • Identify at-risk immunosuppressed, dermatology patients
  • Examine the evidence of recommendations for screening, vaccination, and opportunistic infection prophylaxis
  • Manage immunosuppressed patients with vaccination, screening, and prophylaxis strategies

More than ever, we are causing iatrogenic immunosuppression in our dermatology patients through the use of corticosteroids, mycophenolate mofetil, methotrexate, azathioprine, cyclosporine, and biologics (e.g. tumor necrosis factor antagonists, IL-12/23 inhibitors, anti B-cell therapies) and in the treatment of chronic diseases. The session reviews and analyzes the literature on disease screening, vaccinations, prophylaxis for opportunistic infections in the context of these medications, and provides recommendations for the optimal management of these patients.